Abstract Submission

  • The Abstract submission deadline was March 24, 2008. The abstract submission process has ended. Notification of acceptance or rejection will be e-mailed in June 2008. The final selection of abstracts for presentation and placement of accepted abstracts in the program format will be made by the Program Committee.
  • Accepted authors are expected to pay their own travel expense s and conference registration fee(s).
  • Please note: There are two oral presentation formats. Abstracts selected for Technology Rapid Fire Sessions will be allotted a 5 minute presentation, with a 5 minute Q&A at the end of each block of 5 presentations. These authors will also be asked to prepare an accompanying poster presentation. Abstracts selected for Clinical Application Sessions will be allotted fifteen minutes of podium time, with 10 minutes for presentation, and five minutes of Q&A.

Abstract Disclosure Statement

In order for your colleagues to properly evaluate the information, analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, SFB requires all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author’s view on the subject. Examples include but are not limited to:

  • Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  • Research grants
  • Employment (full- or part-time)
  • Ownership or partnership
  • Consulting fees or other remuneration (payment)
  • Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  • Receipt of royalties
  • Speakers bureau

Disclosure information is collected on the online abstract form. Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the conflict of interest/disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.

Oral or Poster Preference

The preferred method of presentation (oral or poster) should be noted. Final determination will be made by the Program Committee.

Content

Content Guidelines are available above. Content should be organized as follows:

  • Statement of purpose
  • Methods, materials and analytical procedures used
  • Summary of the results in sufficient detail to support conclusion
  • Conclusions reached (do not state “results will be discussed”)
  • References to published literature

NOTE: Common reasons for abstract rejection are:

  1. Poorly supported research hypothesis/objective/rationale
  2. Experimental plan vague and/or not well documented/described
  3. Insufficient data collected
  4. Poor analysis of the data
  5. Conclusions not supported by the results
  6. Poor grammar/figures/tables

Tables and Graphs

Tables and graphs should be embedded in the submitted Microsoft Word or Adobe Acrobat document and must be of sufficient resolution to be reproduced clearly, typically at 300 dpi.

Acknowledgment of Receipt of Abstracts

Once your abstract has been completed, you will have the option to e-mail an acknowledgment of receipt to yourself and/or your co-authors on the “Review My Work” page of the online submission system.

Online Revisions

You may revise your abstract until 11:59 p.m. Eastern Standard Time on March 15, 2008, by returning to the site and logging in again. After clicking on the link to access your abstract, you will see the “Review My Work” page. Click on the step you wish to revise. The system will return you to the “Review My Work” page when you are finished. After the deadline, all completed abstracts in the system will be sent to the Program Committee for review. Any abstracts left “incomplete” will not be sent for review. There are no exceptions.

Abstract Withdrawals

To remove an abstract from consideration, and publishing, you MUST notify the program chair no later than July 15, 2008. If an abstract accepted for publication must be withdrawn after July 15th, the submitting author may be required to pay a publishing fee of $50. An author whose paper is accepted, and who does not present the work in Atlanta, or provide notice of withdrawal, will be charged a $50 publishing fee. If the abstract must be withdrawn, the SFB office must be notified in writing via fax at (856) 439-0525 or via e-mail at info@biomaterials.org.

Publication

Accepted abstracts will be published in the Transactions of the Society For Biomaterials, a referenced, copyrighted publication of the Society For Biomaterials.

Submit only ONE abstract for each presentation; DO NOT submit multiple copies of the same abstract and DO NOT submit in masked format. If you require assistance with the abstract submission process, please contact OASIS technical support:

E-mail: support@abstractsonline.com
Phone: (217) 398-1792
Monday-Friday
10:00 a.m. - 6:00 p.m. Eastern Time
Fax: (217) 355-0101

Registration Requirements

Accepted authors are expected to pay their own travel expenses and conference registration fee(s).

Review Procedures

Submitted abstracts that provide a substantial contribution to the field of biomaterials and follow the published abstract submission instructions will be accepted for peer review. Reviewers will be selected by the Program Committee. Abstracts that do not meet the focus of the session category as requested by the authors may be reassigned to another session.

Presenting Author Contact Responsibilities

The person submitting the abstract identifies the author who will be designated as the presenting author. The presenting author will serve as the primary contact on the abstract. The presenter must be one of the co-authors listed on the submitted abstract. The presenting author will be the main point of contact for information regarding the submission and is responsible for the following:

  • Forwarding acceptance/rejection of the abstract to all authors.
  • Ensuring that all authors have read the abstract and have agreed to be co-authors.
  • Failure to obtain approval from all authors may result in the presenting author being barred from making presentations at future SFB meetings.
  • Notifying all co-authors of any additions, deletions and changes to the program, as may be corresponded by SFB, in a timely manner.
  • If the abstract is accepted for presentation, it is the responsibility of the presenting author to forward all correspondence to the other authors. The presenting author must adhere to all published guidelines.

Failure to Present

The presenting author is expected to present the paper. If emergencies at the time of the meeting prohibit the participation of the designated author, the chair(s) of the session and the Program Committee chair must be notified of the name of the replacement speaker prior to the meeting. It is the presenting author’s obligation to ensure that the abstract is presented. Failure to present an oral or poster presentation at the scheduled times may result in the presenting author being barred from making presentations at future SFB meetings.

Notification

Notification of acceptance or rejection will be e-mailed in June 2008. The final selection of abstracts for presentation and placement of accepted abstracts in the program format will be made by the Program Committee.

Poster and oral presentations are viewed as equally important components of the meeting. Abstracts assigned to an oral presentation should stimulate discussion. In this case, the audience should also benefit from questions and answers following the presentation. Many types of studies lend themselves more to a poster presentation than to a podium presentation. Abstracts need to be submitted to the most appropriate category from the program topic list. Final assignment will be the decision of the Program Committee.

Abstracts accepted for oral presentation in a Clinical Application Session will be provided ten minutes for didactic presentation, followed by five minutes for discussion. Abstracts accepted for oral presentation in a Technology Rapid Fire Session will be provided five minutes for didactic presentation; a general discussion period will follow after a group of presentations. The aforementioned time schedule will be enforced.  The nature of the multiple session formats makes it imperative that these time limits be strictly observed by all participants. Oral presentations should be prepared in PowerPoint for LCD projection.

Abstracts accepted for poster presentation will be provided a panel for mounting their descriptive material. Poster presenters will be provided a poster board that is 4 feet high x 4 feet wide (1.22 m high x 1.22 m wide) for mounting their descriptive material. Presenting authors must set their posters up before the start of the first scheduled poster session. Presenting authors must be at their poster during the scheduled Poster Session listed in the Final Program and adhere to set-up/tear-down instructions included in the acceptance notification.